Preferred Drug List (PDL) and Pharmacy Quarterly Update


PDF Version

TO: Pharmacies, Physicians, Physician Assistants, Nurse Practitioners, Oral Surgeons, Optometrists, Dentists, FQHCs, RHCs, Mental Health Service Providers and Nursing Homes


RE: Preferred Drug List (PDL) and Pharmacy Quarterly Update



Effective July 1, 2022, the Alabama Medicaid Agency will:


1.   Remove prior authorization (PA) from dexmethylphenidate ER (generic Focalin XR). Brand Focalin XR will now require PA.


2.   Update the PDL to reflect the quarterly updates listed below: 

PDL Additions

Dexmethylphenidate ER (generic)

Cerebral Stimulants/Agents Used for ADHD (Long-Acting)

PDL Deletions

Adhansia XR

Cerebral Stimulants/ Agents Used for ADHD (Long-Acting)

Focalin XR

Cerebral Stimulants/ Agents Used for ADHD (Long-Acting)


For additional PDL and coverage information, visit our drug look-up site at


The Prior Authorization (PA) request form and criteria booklet should be utilized by the prescriber or the dispensing pharmacy when requesting a PA. The PA request form can be completed and submitted electronically on the Agency’s website at


Providers requesting PAs by mail or fax should send requests to:



Medicaid Pharmacy Administrative Services

P. O. Box 3210 Auburn, AL 36832-3210

Fax: 1-800-748-0116

Phone: 1-800-748-0130


Incomplete PA requests or those failing to meet Medicaid criteria will be denied. If the prescriber believes medical justification should be considered, the prescriber must document this on the form or submit a written letter of medical justification along with the PA form to Kepro. Additional information may be requested. Staff physicians will review this information.

The Current Procedural Terminology (CPT) and Current Dental Terminology (CDT) codes descriptors, and other data are copyright © 2022 American Medical Association and © 2022 American Dental Association (or such other date publication of CPT and CDT). All rights reserved. Applicable FARS/DFARS apply.